Total Payments
$3,033
2024 Payments
$369.01
Companies
14
Transactions
24
Medicare Patients
569
Medicare Billing
$59,555
Payment Breakdown by Category
Food & Beverage$1,773 (58.5%)
Other$1,260 (41.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,773 | 22 | 58.5% |
| Honoraria | $1,260 | 2 | 41.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Epizyme, Inc., | $660.00 | 1 | $0 (2022) |
| Ipsen Biopharmaceuticals, Inc | $600.00 | 1 | $0 (2022) |
| Rigel Pharmaceuticals, Inc. | $317.94 | 4 | $0 (2023) |
| Seagen Inc. | $263.01 | 2 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $223.22 | 3 | $0 (2022) |
| Amgen Inc. | $207.73 | 4 | $0 (2023) |
| GENZYME CORPORATION | $204.63 | 2 | $0 (2024) |
| Genmab U.S., Inc. | $138.91 | 1 | $0 (2024) |
| Karyopharm Therapeutics Inc. | $128.91 | 1 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $115.12 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $369.01 | 3 | Genmab U.S., Inc. ($138.91) |
| 2023 | $579.37 | 7 | Seagen Inc. ($263.01) |
| 2022 | $1,510 | 7 | Epizyme, Inc., ($660.00) |
| 2021 | $574.64 | 7 | AstraZeneca Pharmaceuticals LP ($199.96) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Genmab U.S., Inc. | — | Food and Beverage | In-kind items and services | $138.91 | General |
| 10/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $115.12 | General |
| Category: IMMUNOLOGY | ||||||
| 04/10/2024 | GENZYME CORPORATION | ENJAYMO (Biological) | Food and Beverage | In-kind items and services | $114.98 | General |
| Category: Hematology | ||||||
| 12/10/2023 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $29.62 | General |
| Category: Oncology | ||||||
| 12/05/2023 | Seagen Inc. | — | Food and Beverage | In-kind items and services | $116.96 | General |
| 05/16/2023 | Amgen Inc. | Blincyto (Biological), Kyprolis | Food and Beverage | In-kind items and services | $29.77 | General |
| Category: Oncology | ||||||
| 04/27/2023 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $145.56 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 04/13/2023 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $146.05 | General |
| Category: Oncology | ||||||
| 04/10/2023 | Amgen Inc. | Blincyto (Biological), Kyprolis | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: Oncology | ||||||
| 03/13/2023 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $89.65 | General |
| Category: Oncology | ||||||
| 11/16/2022 | Amgen Inc. | Kyprolis (Drug) | Food and Beverage | In-kind items and services | $34.05 | General |
| Category: Oncology | ||||||
| 11/03/2022 | Epizyme, Inc., | — | Honoraria | Cash or cash equivalent | $660.00 | General |
| 11/03/2022 | Ipsen Biopharmaceuticals, Inc | TAZVERIK (Drug) | Honoraria | Cash or cash equivalent | $600.00 | General |
| Category: Oncology | ||||||
| 10/19/2022 | PFIZER INC. | BOSULIF (Drug), BESPONSA, PAXLOVID | Food and Beverage | In-kind items and services | $38.30 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 08/29/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $23.26 | General |
| 08/10/2022 | Rigel Pharmaceuticals, Inc. | Tavalisse (Drug) | Food and Beverage | In-kind items and services | $25.52 | General |
| Category: Hematology | ||||||
| 04/13/2022 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $128.91 | General |
| Category: Oncology | ||||||
| 12/09/2021 | Rigel Pharmaceuticals, Inc. | Tavalisse (Drug) | Food and Beverage | In-kind items and services | $52.87 | General |
| Category: Hematology | ||||||
| 09/20/2021 | MorphoSys, US Inc. | MONJUVI (Drug) | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: Oncology | ||||||
| 08/18/2021 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $119.17 | General |
| 06/15/2021 | Amgen Inc. | Kyprolis (Drug) | Food and Beverage | In-kind items and services | $122.15 | General |
| Category: Oncology | ||||||
| 05/24/2021 | Rigel Pharmaceuticals, Inc. | Tavalisse (Drug) | Food and Beverage | In-kind items and services | $93.99 | General |
| Category: Hematology | ||||||
| 05/12/2021 | AbbVie Inc. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $93.02 | General |
| Category: ONCOLOGY | ||||||
| 04/28/2021 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $80.79 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 70 | 116 | $35,616 | $7,852 |
| 2022 | 5 | 158 | 252 | $65,715 | $16,408 |
| 2021 | 6 | 183 | 294 | $69,229 | $18,990 |
| 2020 | 5 | 158 | 332 | $66,520 | $16,306 |
Total Patients
569
Total Services
994
Medicare Billing
$59,555
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 23 | 46 | $18,354 | $4,203 | 22.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 18 | 30 | $8,070 | $1,937 | 24.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 29 | 40 | $9,192 | $1,711 | 18.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 51 | 84 | $33,578 | $8,426 | 25.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 33 | 50 | $13,542 | $3,421 | 25.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 35 | 56 | $10,294 | $2,644 | 25.7% |
| 38222 | Biopsy and aspiration of bone marrow sample for diagnosis | Facility | 2022 | 23 | 23 | $4,869 | $1,093 | 22.5% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 2022 | 16 | 39 | $3,432 | $823.43 | 24.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 36 | 69 | $24,285 | $6,976 | 28.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 43 | 91 | $21,819 | $5,893 | 27.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 45 | 73 | $11,877 | $3,304 | 27.8% |
| 38222 | Diagnostic aspirations and biopsies of bone marrow | Facility | 2021 | 37 | 37 | $7,965 | $1,953 | 24.5% |
| 38221 | Biopsy of bone marrow | Facility | 2021 | 11 | 11 | $2,144 | $552.62 | 25.8% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 2021 | 11 | 13 | $1,139 | $310.57 | 27.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 71 | 224 | $48,388 | $11,797 | 24.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 49 | 64 | $8,968 | $2,141 | 23.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 13 | 16 | $4,896 | $1,248 | 25.5% |
| 38222 | Bone marrow biopsy and aspiration | Facility | 2020 | 14 | 16 | $3,498 | $890.57 | 25.5% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 11 | 12 | $770.00 | $229.80 | 29.8% |
About Frances Arters, PA-C
Frances Arters, PA-C is a Physician Assistant healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/19/2015. The National Provider Identifier (NPI) number assigned to this provider is 1700270444.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Frances Arters, PA-C has received a total of $3,033 in payments from pharmaceutical and medical device companies, with $369.01 received in 2024. These payments were reported across 24 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,773).
As a Medicare-enrolled provider, Arters has provided services to 569 Medicare beneficiaries, totaling 994 services with total Medicare billing of $59,555. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Boston, MA
- Active Since 03/19/2015
- Last Updated 05/01/2023
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1700270444
Products in Payments
- TAZVERIK (Drug) $600.00
- Tavalisse (Drug) $172.38
- Kyprolis (Drug) $156.20
- ADCETRIS (Biological) $146.05
- Rezlidhia (Drug) $145.56
- XPOVIO (Drug) $128.91
- HYQVIA (Biological) $115.12
- ENJAYMO (Biological) $114.98
- VENCLEXTA (Drug) $93.02
- SARCLISA (Biological) $89.65
- Blincyto (Biological) $51.53
- BOSULIF (Drug) $38.30
- Orserdu (Drug) $29.62
- MONJUVI (Drug) $12.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Boston
Andrea Milligan, P.a.-C, P.A.-C
Physician Assistant — Payments: $46,222
Physician Assistant $46,222
Lauren Rousseau, Pa-C, PA-C
Physician Assistant — Payments: $24,236
Physician Assistant $24,236
Shari Tomasetti, Pa, PA
Physician Assistant — Payments: $10,440
Physician Assistant $10,440
Tiffany Andrade, Pa-C, PA-C
Physician Assistant — Payments: $8,438
Physician Assistant $8,438
Margaret Naclerio
Physician Assistant — Payments: $8,434
Physician Assistant $8,434
Hillary Du
Physician Assistant — Payments: $7,238
Physician Assistant $7,238